Endpoints Webinars

Life sciences marketers work with long sales cycles and products that require market education — which make webinars one of the most essential tools in the biopharma demand generation toolbox. 

Endpoints webinars are a turn-key solution — let us handle the audience generation, content, marketing, and tech.

Upcoming Webinars

Transformative approaches to clinical development: Scaling adoption across the industry

Developing and using digital biomarkers

Plasmid DNA Insights: Expanded focus on CMC in gene & cell therapy development

How scalable and intensified is your CAR-T process?

Are we ready for the medicines of tomorrow? Creating the infrastructure for the era of genomic medicine

past Webinars

Realizing the full potential of clinicogenomics

Hot topics in Immunoassay Bioanalysis - navigating the immunogenicity and biomarker requirements for clinical trials

The Great Debate: Internal vs. external manufacturing for advanced therapies

Predict placebo response using patient psychology to increase trial power

Can sponsors collect data in Expanded Access (EAPs) and Named Patient Programs (NPPs)?

Clinical trial diversity in the Covid-19 era — are we seeing a paradigm shift?

The benefits of running clinical trials in China

Where does your organization sit on the omnichannel maturity curve?

Flattening the 'valley of death:' New tools in the hunt for better preclinical R&D

Repurposing drugs for new indications: benefits and challenges

Leveraging APAC partnerships to de-risk clinical trials

Patient-First R&D: Why the patient experience should be at the center of clinical trial design

Navigating the path to the clinic and beyond for gene therapies

Beyond AAV 1.0

Enabling multidimensional tumor immunogenomics for advancing biomarker discovery

Breakthrough Technologies to Accelerate Biologic Drug Discovery, Cell Line Development and Biomanufacturability

How the World’s First Biolabs Client Portal GALEXI™ Delivers Real-Time Study Management for Biotechs

The Patient Voice in Rare Disease Research

Redefining conditioning for a new era of gene therapy

DEL Kits Special Event: A New Method of Hit Discovery

Optimizing Direct-to-Patient Clinical Supply for Decentralized Clinical Trials

Amgen’s BiTE® Platform and the Next Frontier in Immuno-Oncology

Innovation in Clinical Research: AI-based Drug Development Tools and the Regulatory Landscape

R&D in an age of Covid-19: Tackling the key issues around starting, or restarting an early-stage study

Solving hard go-to-market challenges

New Platform for Target-to-Hit: From Fragment Screen to Structure-based Drug Discovery

Introduction to Self-Service DNA-Encoded libraries (DELs)

Keeping Pace with Big Pharma - On A Start Up Budget

Putting AI in R&D

Managing Global Studies with Regional Partners

Faster, More Efficient Trials: Novel Trial Designs using Digital Twins

Why Australia is the World’s Leading Early Phase Destination – Rapid Start-up, No IND Required, and a Government-Backed Refund on Almost Half of all Trial Costs

The Transformation of Clinical Trial Design and Operations: A Panel Discussion on COVID-19 as a Catalyst for Decentralized Trials

AI, Digital Twins, and the Future of Clinical Research

When cell and gene therapies surge to market, how resilient will your cell sourcing infrastructure be?

The Australian Early Phase Biosimilars Clinical Trial Landscape - How Agilex Biolabs and Nucleus Network Work Together

The FDA and Covid-19: New rules for the R&D road

Novel oncology trial designs with a personalized ctDNA assay

Derisking orphan drug programs in 2020 and beyond

A Clinical Investigator’s Perspective: Novel Oncology Therapy During & Beyond the COVID Pandemic

Home Nursing Support for Clinical Trials

Running First-in-human and Vaccines Studies in Australia

How Easy is it to Move your Clinical Trials to Australia?

Utilizing the immunoSEQ Assay in Clinical Trials

The Covid-19 challenge: Keeping the supply chain intact

Dealmaking in a time of coronavirus

Endpoints Editor John Carroll's Covid - 19 webinar series

Advancing Oncology Clinical Trials in Asia-Pacific

Asia-Pacific – a Global hub for Hepatology Clinical Trials

Perspectives on Partnering Post-Pandemic

Clinical Trial Continuity in Asia-Pacific during the COVID-19 Pandemic

The Australian Advantage: De-risk your early phase trials

Rapid Deployment of Remote Trials During Containment

RWD for R&D: Examples from Immunology, Rheumatology and Other Chronic Diseases

Designing a turnkey orphan drug program

The do’s and don’ts of managing a pivotal gene therapy trial

You've got that coveted accelerated regulatory pathway. Now what?

Developing better assays for biopharma with a CRO partner

Are you really ready for your end of phase 2 meeting?

How to run a Digital Trial and reduce time in development by 50%

Improving Clinical Trial Quality with Best Practices for E-Clinical Technology

Developing a digital therapeutics trial

The Experts: Real World Endpoints

Designing Next-Gen Oncology Trials

ctDNA as a biomarker for monitoring treatment response and molecular recurrence in early-stage and metastatic cancers

How to get the most out of your Phase I biologic study

The Alzheimer's Trials of the Future